Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development.
Journal: Cancer discovery
Published: December 12, 2023
Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer.
Journal: Cancer research communications
Published: October 28, 2022
NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model.
Journal: Oncotarget
Published: December 15, 2021
Correction: Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 02, 2021
Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones.
Journal: The Journal of clinical investigation
Published: August 24, 2020
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 02, 2020
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 12, 2019
Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation.
Journal: The Journal of clinical investigation
Published: August 09, 2019
Circulating Tumor DNA: Measurement and Clinical Utility.
Journal: Annual review of medicine
Published: August 29, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026